The first immunotherapy to use genetically engineered CD4 T-cells and targeting MAGE-A3 ... director of the Lombardi Comprehensive Cancer Center at Georgetown University, in Washington, DC, ...

After the first and third DC vaccinations, no changes were found in absolute numbers of CD3+, CD4+, and CD8+ cells per µL blood (Data Supplement, Fig S2A). Because of insufficient numbers of ...

Two CD4+ T-cell epitopes and nine CD8+ T cell epitopes were found to be 100 percent homologous across all the ... "Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 ...

The relationship between the timing of the initiation of antiretroviral therapy (ART) after infection with human immunodeficiency virus type 1 (HIV-1) and the recovery of CD4+ T-cell counts is unkn ...

About 60 percent of the pulmonary CD4+CD3+ cells in patients with moderate-to-severe persistent asthma were not class II MHC–restricted CD4+ T cells but, rather, natural killer T cells.

This article explores low CD4-cell counts among patients who control viral replication without antiretroviral therapy. Is immune activation a possible mechanism for this paradoxical response to HIV?

Patients living with HIV and with low CD4+ T-cell counts are among the populations of immunocompromised individuals who have a weaker response to the COVID-19 vaccines. A booster vaccine dose ...